Markets.News

CELC  CELCUITY INC

+ add to watchlist

$105.25

celcuity is a biotech company developing state-of-the-art cell-based assays using our proprietary functional cellular analysis platform. we directly assess the functionality of the disease-related signaling pathways of a patient's diseased cells ex vivo to determine whether a drug therapy has the intended effect on those cells. the patient specific cellular data we provide offers clinicians and pharmaceutical companies unique insight into a patient's response to a drug therapy, and it will change the paradigm of personalized medicine.

Mkt Cap: $4.87B

52 Week High: $112.64

P/E: 0.00

52 Week Low: $7.58

Dividend: $0.00

Shares Outstanding: 46.27M

This news is delayed by 15 minutes, sign up now to get live news & full features.